GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis

BACKGROUND: GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma [HCC] and Of its treatment with sorafeNib) is a global, prospective, non-interventional study undertaken to evaluate the safety of sorafenib in patients with unresectable HCC in real-life practice, includin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lencioni, R, Kudo, M, Ye, S-L, Bronowicki, J-P, Chen, X-P, Dagher, L, Furuse, J, Geschwind, J F, de Guevara, L Ladrón, Papandreou, C, Takayama, T, Yoon, S K, Nakajima, K, Lehr, R, Heldner, S, Sanyal, A J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265239/
https://www.ncbi.nlm.nih.gov/pubmed/24283303
http://dx.doi.org/10.1111/ijcp.12352

Ejemplares similares

Ejemplares similares